Split History
IBIO split history picture
iBio (IBIO) has 1 split in our IBIO split history database. The split for IBIO took place on June 11, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of IBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.

When a company such as iBio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the IBIO split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into iBio shares, starting with a $10,000 purchase of IBIO, presented on a split-history-adjusted basis factoring in the complete IBIO split history. IBIO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/02/2012
End date: 09/30/2022
Start price/share: $10.10
End price/share: $0.17
Dividends collected/share: $0.00
Total return: -98.32%
Average Annual Total Return: -33.53%
Starting investment: $10,000.00
Ending investment: $168.37
Years: 10.00
iBio is a developer of biopharmaceuticals and FastPharming Manufacturing System (the FastPharming System) ®. Co. applies its technologies to develop product candidates to fight fibrotic diseases, cancers, and infectious diseases. Co. uses its FastPharming Manufacturing System and Glycaneering Services™ to build biologic drug candidates. Co.'s segments are: Biopharmaceuticals, which includes development and licensing in therapeutics and vaccines; and Bioprocessing, which includes services (FastPharming, process development, manufacturing, as well as bioanalytical and other services) and products (growth factors, lectins, and monoclonal antibodies) for research and further manufacturing uses. According to our IBIO split history records, iBio has had 1 split.
Date Ratio
06/11/20181 for 10
IBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ICAD Split History
ICCC Split History
ICLR Split History
ICUI Split History
IDRA Split History
IDXG Split History
IDXX Split History
IGC Split History
ILMN Split History
IMMY Split History

Email EnvelopeFree IBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

American Virtual Cloud Technologies, Inc. (AVCT)
Avenue Therapeutics, Inc. (ATXI)
Annaly Capital Management, Inc. (NLY)
CohBar, Inc. (CWBR)
TOP Ships Inc. (TOPS)
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Nabriva Therapeutics plc (NBRV)
NeuroBo Pharmaceuticals, Inc. (NRBO)
First Wave BioPharma, Inc. (FWBI)
Palatin Technologies, Inc. (PTIN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

IBIO Insider Buying

IBIO Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.